title: Combined restitutive therapy for treatment of immunosuppressive refractory Crohn disease.
authors.affiliation: *School of Medicine, MD/PhD Program †Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, University of North Carolina, Chapel Hill ‡New Hanover Regional Medical Center, Wilmington, NC.
authors.forename: Jason R
authors.initials: JR
authors.lastname: Goldsmith
authors.forename: Maureen
authors.initials: M
authors.lastname: Kelly
authors.forename: Katherine B
authors.initials: KB
authors.lastname: Freeman
authors.forename: Debora
authors.initials: D
authors.lastname: Duro
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D000701:Analgesics, Opioid / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology; D004361:Drug Tolerance; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008139:Loperamide / Q000627:therapeutic use*; D012074:Remission Induction
chemical_list: D000276:Adjuvants, Immunologic; D000701:Analgesics, Opioid; D007166:Immunosuppressive Agents; D008139:Loperamide; D016178:Granulocyte-Macrophage Colony-Stimulating Factor